Drugs Policy

Lord Taverne Excerpts

Thursday 26th June 2014 Lords Chamber

[Lord Ahmad of Wimbledon]

First, I pay tribute to the work the noble Baroness has done in this field. She has brought to the fore on many occasions the importance of reviewing drugs policy. The Government have taken a broad view of this. If we look at the statistics, it is commendable that drug usage domestically is down and we have seen a greater emphasis being put on helping people overcome drugs issues. Nevertheless, she may well be aware that there is an international comparators report due within the next two to three months, and we will be reviewing what we find in terms of best practice across a range of countries, not just within the EU.

[Lord Taverne (LD)]

My Lords, will the Government support the modernisation of schedule 1 through an evidence-based review process so that the great advances in medical science in the UK and elsewhere can be reflected in the wider availability of drugs for medical use?

[Lord Ahmad of Wimbledon]

I have already said that we are constantly reviewing our drugs policy to ensure that what we do is based on prevention and cure but also on enforcement. Evidence has shown that our current balanced approach is paying dividends and we need to ensure that we do not have a knee-jerk reaction to what is being proposed. I have already mentioned the comparators report, and other reviews internally will ensure that we continue to have a balanced view of this particularly sensitive area.